These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 20073612

  • 1. Clinical utility of adjunctive high-risk human papillomavirus DNA testing in women with Papanicolaou test findings of atypical glandular cells.
    Zhao C, Florea A, Austin RM.
    Arch Pathol Lab Med; 2010 Jan; 134(1):103-8. PubMed ID: 20073612
    [Abstract] [Full Text] [Related]

  • 2. Significance of High-Risk Human Papillomavirus Testing for Atypical Glandular Cells on Cervical Cytology.
    Komatsu H, Oishi T, Osaku D, Sawada M, Kudoh A, Nonaka M, Chikumi J, Sato S, Harada T.
    Acta Cytol; 2018 Jan; 62(5-6):405-410. PubMed ID: 29990964
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.
    Bandyopadhyay S, Austin RM, Dabbs D, Zhao C.
    Arch Pathol Lab Med; 2008 Dec; 132(12):1874-81. PubMed ID: 19061283
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical significance of atypical glandular cells in Pap tests: An analysis of more than 3000 cases at a large academic women's center.
    Pradhan D, Li Z, Ocque R, Patadji S, Zhao C.
    Cancer Cytopathol; 2016 Aug; 124(8):589-95. PubMed ID: 27115423
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears.
    Derchain SF, Rabelo-Santos SH, Sarian LO, Zeferino LC, de Oliveira Zambeli ER, do Amaral Westin MC, de Angelo Andrade LA, Syrjänen KJ.
    Gynecol Oncol; 2004 Dec; 95(3):618-23. PubMed ID: 15581973
    [Abstract] [Full Text] [Related]

  • 10. Clinical performance of the aptima HPV assay in 4196 women with positive high-risk HPV and ASC-US cytology: A large women hospital experience.
    Wang T, Pradhan D, Zhang H, Matsko J, Zhao C.
    Diagn Cytopathol; 2021 Jan; 49(1):5-10. PubMed ID: 32857920
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Can we predict histological outcome of distinctive cohorts of patients with glandular cell abnormalities on ThinPrep Papanicolaou testing based on human papillomavirus status, age, and associated squamous abnormalities?
    Harbhajanka A, Dahoud W, Michael CW.
    Diagn Cytopathol; 2019 Oct; 47(10):1028-1036. PubMed ID: 31359607
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Histopathologic follow-up and human papillomavirus DNA test results in 290 patients with high-grade squamous intraepithelial lesion Papanicolaou test results.
    Gao FF, Austin RM, Zhao C.
    Cancer Cytopathol; 2011 Dec 25; 119(6):377-86. PubMed ID: 21774093
    [Abstract] [Full Text] [Related]

  • 15. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.
    Zhao C, Amin M, Weng B, Chen X, Kanbour-Shakir A, Austin RM.
    Arch Pathol Lab Med; 2013 Jul 25; 137(7):942-7. PubMed ID: 23050808
    [Abstract] [Full Text] [Related]

  • 16. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
    Zhou H, Mody RR, Luna E, Armylagos D, Xu J, Schwartz MR, Mody DR, Ge Y.
    Cancer Cytopathol; 2016 May 25; 124(5):317-23. PubMed ID: 26774025
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States.
    Liao SY, Rodgers WH, Kauderer J, Bonfiglio TA, Walker JL, Darcy KM, Carter R, Hatae M, Levine L, Spirtos NM, Stanbridge EJ.
    Int J Cancer; 2009 Nov 15; 125(10):2434-40. PubMed ID: 19670419
    [Abstract] [Full Text] [Related]

  • 19. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.
    Zhao C, Li Z, Austin RM.
    Am J Clin Pathol; 2013 Jul 15; 140(1):47-54. PubMed ID: 23765533
    [Abstract] [Full Text] [Related]

  • 20. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B, Li Z, Griffith CC, Yan S, Chen C, Ding X, Liang X, Yang H, Zhao C.
    Cancer Cytopathol; 2015 Jul 15; 123(7):428-34. PubMed ID: 25954852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.